On 29 September, Suzhou Novoprotein Scientific Co., Ltd. was listed on the STAR Market. The stock name is Novoprotein, the stock code is 688137. SH, with the issue price is 106.19 CNY / share, which broke after the opening, with a market capitalization of over CNY 5.6 billion.

Medix Biochemica, a Finnish producer of raw materials for in vitro diagnostics, said on Monday that it has acquired Bioresource Technology, a US-based provider of base matrices and other raw materials for IVD manufacturing.

On May 18, Yunkang Group was listed on Hong Kong Exchanges and Clearing Limited (HKEX), stock code: 2325.HK. At press time, it opened down over 10% with a total market capitalisation of approximately HK$4.3 billion.

Recently, Bioeast Biotech announced the completion of the A+ round of financing of RMB 150 million. This round of financing was exclusively invested by LYFE CAPITAL.

University of Notre Dame researchers have discovered another way tumor cells transfer genetic material to other cells in their microenvironment, causing cancer to spread.

The continuous outbreak of the 2021 epidemic has drawn attention to the issue of upstream raw materials in China's IVD industry.

The 2nd Key Raw Material & Parts Forum of China will be held at Primus Hotel Nanchang International Expo City (Nanchang, China) on October 26 in 2022.

Ever since the first barcode appeared on a pack of chewing gum in 1974, the now-ubiquitous system has enabled manufacturers, retailers and consumers to quickly and effectively identify, characterize, locate and track products and materials.

Medix Biochemica, a global leader in critical IVD raw materials, has acquired all of the shares of Diaclone SAS ("Diaclone"). Through acquisition, Medix Biochemica broadens its portfolio of critical raw materials for the in-vitro diagnostics ("IVD") industry and expands its global network.

On May 16, Mindray Medical announced that it intends to acquire 100% of the equity of HytestInvest Oy in Finland and its subsidiaries.